Journal article

CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Lucas, C., Scott, L., Carmell, N., Holcroft, A., Hills, R., Burnett, A., & Clark, R. (2018). CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML. Blood Advances, 2(9), 964–968.

MLA Style

Lucas, C., et al. “CIP2A- And SETBP1-Mediated PP2A Inhibition Reveals AKT S473 Phosphorylation to Be a New Biomarker in AML.” Blood Advances, vol. 2, no. 9, American Society of Hematology: Blood Advances, 2018, pp. 964–68.

Chicago Style

Lucas, C, L Scott, N Carmell, A Holcroft, R Hills, A Burnett, and R Clark. 2018. “CIP2A- And SETBP1-Mediated PP2A Inhibition Reveals AKT S473 Phosphorylation to Be a New Biomarker in AML.” Blood Advances 2 (9): 964–68.
Share
Print

Access Document

Files:: cip2a.pdf

(Preview, Version of record, pdf, 793.9KB, Terms of use)

Publisher copy:: 10.1182/bloodadvances.2017013615

Authors

+ Lucas, C More by this author

Role:: Author

+ Scott, L More by this author

Role:: Author

+ Carmell, N More by this author

Role:: Author

+ Holcroft, A More by this author

Role:: Author

+ Hills, R More by this author

Institution:: University of Oxford
Division:: Medical Sciences Division
Department:: Nuffield Dept of Population Health
Sub department:: Clinical Trial Service Unit
Department:: Unknown
Role:: Author
ORCID:: 0000-0003-0166-0062

More authors...

Publisher:: American Society of Hematology: Blood Advances
Journal:: Blood Advances More from this journal
Volume:: 2
Issue:: 9
Pages:: 964-968
Publication date:: 2018-05-08
Acceptance date:: 2018-03-16
DOI:: 10.1182/bloodadvances.2017013615
EISSN:: 2473-9529

Pubs id:: pubs:930210
UUID:: uuid:7612f6ec-da7d-46ae-94f0-796249476c40
Local pid:: pubs:930210
Source identifiers:: 930210
Deposit date:: 2019-02-27

Terms of use

Copyright holder:: American Society of Hematology
Copyright date:: 2018
Notes:: © 2018 by The American Society of Hematology. This is the publisher's version

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP